Abbott Laboratories Stock Analysis

ABT Stock  USD 107.28  2.01  1.91%   
Abbott Laboratories is undervalued with Real Value of 109.84 and Target Price of 110.65. The main objective of Abbott Laboratories stock analysis is to determine its intrinsic value, which is an estimate of what Abbott Laboratories is worth, separate from its market price. There are two main types of Abbott Laboratories' stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Abbott Laboratories' performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Abbott Laboratories' stock to identify patterns and trends that may indicate its future price movements.
The Abbott Laboratories stock is traded in the USA on New York Stock Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Abbott Laboratories is usually not traded on Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day, Labour Day. Abbott Stock trading window is adjusted to America/New York timezone. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Abbott Laboratories' ongoing operational relationships across important fundamental and technical indicators.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Abbott Laboratories. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of labor statistics.
For more information on how to buy Abbott Stock please use our How to Invest in Abbott Laboratories guide.

Abbott Stock Analysis Notes

About 77.0% of the company shares are held by institutions such as insurance companies. The book value of Abbott Laboratories was presently reported as 22.26. The company last dividend was issued on the 12th of April 2024. Abbott Laboratories had 10000:4798 split on the 2nd of January 2013. Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois. Abbott Laboratories operates under Medical Devices classification in the United States and is traded on New York Stock Exchange. It employs 113000 people. For more info on Abbott Laboratories please contact Miles White at 224 667 6100 or go to https://www.abbott.com.

Abbott Laboratories Quarterly Total Revenue

10.24 Billion

Abbott Laboratories Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Abbott Laboratories' investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Abbott Laboratories or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Abbott Laboratories generated a negative expected return over the last 90 days
Abbott Laboratories has a strong financial position based on the latest SEC filings
Over 77.0% of the company shares are held by institutions such as insurance companies
Latest headline from smh.com.au: Sharemarket set for soft start amid interest rate uncertainty

Abbott Laboratories Upcoming and Recent Events

Earnings reports are used by Abbott Laboratories to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Abbott Laboratories previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
17th of April 2024
Upcoming Quarterly Report
View
18th of July 2024
Next Financial Report
View
31st of March 2024
Next Fiscal Quarter End
View
22nd of January 2025
Next Fiscal Year End
View
31st of December 2023
Last Quarter Report
View
31st of December 2023
Last Financial Announcement
View

Abbott Largest EPS Surprises

Earnings surprises can significantly impact Abbott Laboratories' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2017-04-19
2017-03-310.430.480.0511 
2015-04-22
2015-03-310.420.470.0511 
2014-04-16
2014-03-310.360.410.0513 
View All Earnings Estimates

Abbott Laboratories Thematic Classifications

In addition to having Abbott Laboratories stock in your portfolios, you can add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your favorite investment opportunity, you can then obtain an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility. If you are a result-oriented investor, you can benefit from optimizing one of our existing themes to build an efficient portfolio against your specific investing outlook.
SRI Sustainable Growth Idea
SRI Sustainable Growth
Large and mid-sized companies that operate under the guidelines of socially responsible investing - SRI
Compulsion Idea
Compulsion
Addiction driven consumer products and services
Obamacare Repeal Idea
Obamacare Repeal
Large healthcare related equities associated with Obamacare

Abbott Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Abbott Laboratories is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Abbott Laboratories backward and forwards among themselves. Abbott Laboratories' institutional investor refers to the entity that pools money to purchase Abbott Laboratories' securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares
Wells Fargo & Co2023-12-31
16.5 M
Bank Of America Corp2023-12-31
16.4 M
Bank Of New York Mellon Corp2023-12-31
15.1 M
Legal & General Group Plc2023-12-31
14.3 M
State Farm Mutual Automobile Ins Co2023-12-31
13.6 M
Polen Capital2023-12-31
13.5 M
Jpmorgan Chase & Co2023-12-31
13.3 M
Hhg Plc2023-12-31
13.2 M
Nuveen Asset Management, Llc2023-12-31
12.4 M
Vanguard Group Inc2023-12-31
156.4 M
Blackrock Inc2023-12-31
134.1 M
Note, although Abbott Laboratories' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Abbott Market Capitalization

The company currently falls under 'Mega-Cap' category with a total capitalization of 182.66 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Abbott Laboratories's market, we take the total number of its shares issued and multiply it by Abbott Laboratories's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Abbott Profitablity

Abbott Laboratories' profitability indicators refer to fundamental financial ratios that showcase Abbott Laboratories' ability to generate income relative to its revenue or operating costs. If, let's say, Abbott Laboratories is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Abbott Laboratories' executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Abbott Laboratories' profitability requires more research than a typical breakdown of Abbott Laboratories' financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Net Profit Margin of 0.14 %, which implies that it may need a different competitive strategy as even a very small decline in it revenue may erase profits and result in a net loss. This is way below average. In the same way, it shows Net Operating Margin of 0.14 %, which entails that for every 100 dollars of revenue, it generated $0.14 of operating income.
Last ReportedProjected for Next Year
Return On Tangible Assets 0.14  0.17 
Return On Capital Employed 0.11  0.10 
Return On Assets 0.08  0.12 
Return On Equity 0.15  0.26 

Management Efficiency

Abbott Laboratories has Return on Asset of 0.0611 % which means that on every $100 spent on assets, it made $0.0611 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.1511 %, implying that it generated $0.1511 on every 100 dollars invested. Abbott Laboratories' management efficiency ratios could be used to measure how well Abbott Laboratories manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Abbott Laboratories' Return On Tangible Assets are comparatively stable compared to the past year. Return On Assets is likely to gain to 0.12 in 2024, whereas Return On Capital Employed is likely to drop 0.10 in 2024. At this time, Abbott Laboratories' Non Current Liabilities Other is comparatively stable compared to the past year. Change To Liabilities is likely to gain to about 44.7 M in 2024, whereas Total Current Liabilities is likely to drop slightly above 8.3 B in 2024.
Last ReportedProjected for Next Year
Book Value Per Share 22.19  23.29 
Net Current Asset Value 0.00  0.00 
Tangible Asset Value 0.00  0.00 
Tangible Book Value Per Share 3.64  3.82 
Enterprise Value Over EBITDA 18.94  19.89 
Price Book Value Ratio 4.96  2.62 
Enterprise Value Multiple 18.94  19.89 
Price Fair Value 4.96  2.62 
Enterprise Value233.1 B244.8 B
The analysis of Abbott Laboratories' management efficiency is an essential part of evaluating and assessing the financial and operational performance of the entity. It is also vital to analyze Abbott Laboratories' future growth prospects and the overall market conditions to determine the value and potential of its stock. The analysis involves studying a range of financial metrics such as revenue, earnings, profit margins, cash flow, debt, market share, and external factors such as economic trends, industry outlook, competition, and government regulations. The goal of Abbott Stock analysis is to determine whether it is undervalued, fairly valued, or overvalued and to make informed investment decisions.
Dividend Yield
0.0209
Forward Dividend Yield
0.0209
Forward Dividend Rate
2.2
Beta
0.74

Technical Drivers

As of the 19th of April, Abbott Laboratories shows the risk adjusted performance of (0.05), and Mean Deviation of 0.9183. Abbott Laboratories technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Put another way, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum, or the prices will eventually revert. We have analyzed thirteen technical drivers for Abbott Laboratories, which can be compared to its peers. Please confirm Abbott Laboratories standard deviation, as well as the relationship between the maximum drawdown and kurtosis to decide if Abbott Laboratories is priced correctly, providing market reflects its regular price of 107.28 per share. Given that Abbott Laboratories has information ratio of (0.15), we suggest you to validate Abbott Laboratories's prevailing market performance to make sure the company can sustain itself at a future point.

Abbott Laboratories Price Movement Analysis

Execute Study
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Abbott Laboratories middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Abbott Laboratories. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.

Abbott Laboratories Outstanding Bonds

Abbott Laboratories issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Abbott Laboratories uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Abbott bonds can be classified according to their maturity, which is the date when Abbott Laboratories has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Abbott Laboratories Predictive Daily Indicators

Abbott Laboratories intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Abbott Laboratories stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Abbott Laboratories Corporate Filings

8K
17th of April 2024
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify
F4
2nd of April 2024
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
15th of March 2024
Other Reports
ViewVerify
F4
4th of March 2024
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
F4
27th of February 2024
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
F4
23rd of February 2024
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
10K
16th of February 2024
Annual report required by the U.S. Securities and Exchange Commission (SEC) of a company financial performance
ViewVerify
13A
13th of February 2024
An amended filing to the original Schedule 13G
ViewVerify

Abbott Laboratories Forecast Models

Abbott Laboratories' time-series forecasting models are one of many Abbott Laboratories' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Abbott Laboratories' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About Abbott Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Abbott Laboratories prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Abbott shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Abbott Laboratories. By using and applying Abbott Stock analysis, traders can create a robust methodology for identifying Abbott entry and exit points for their positions.
Last ReportedProjected for Next Year
Pretax Profit Margin 0.17  0.21 
Operating Profit Margin 0.16  0.21 
Net Profit Margin 0.14  0.15 
Gross Profit Margin 0.55  0.62 

Current Abbott Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Abbott analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Abbott analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
110.65Strong Buy25Odds
Abbott Laboratories current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Abbott analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Abbott stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Abbott Laboratories, talking to its executives and customers, or listening to Abbott conference calls.
Abbott Analyst Advice Details

Abbott Stock Analysis Indicators

Abbott Laboratories stock analysis indicators help investors evaluate how Abbott Laboratories stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Abbott Laboratories shares will generate the highest return on investment. By understating and applying Abbott Laboratories stock analysis, traders can identify Abbott Laboratories position entry and exit signals to maximize returns.
Begin Period Cash Flow9.9 B
Long Term Debt13.6 B
Common Stock Shares Outstanding1.7 B
Total Stockholder Equity38.6 B
Tax ProvisionB
Quarterly Earnings Growth Y O Y-0.067
Property Plant And Equipment Net11.3 B
Cash And Short Term Investments7.3 B
Cash6.9 B
Accounts Payable4.3 B
Net DebtB
50 Day M A114.264
Total Current Liabilities13.8 B
Other Operating Expenses33.6 B
Non Current Assets Total50.5 B
Forward Price Earnings23.6407
Non Currrent Assets OtherB
Stock Based Compensation644 M
When determining whether Abbott Laboratories is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Abbott Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Abbott Laboratories Stock. Highlighted below are key reports to facilitate an investment decision about Abbott Laboratories Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Abbott Laboratories. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of labor statistics.
For more information on how to buy Abbott Stock please use our How to Invest in Abbott Laboratories guide.
Note that the Abbott Laboratories information on this page should be used as a complementary analysis to other Abbott Laboratories' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.

Complementary Tools for Abbott Stock analysis

When running Abbott Laboratories' price analysis, check to measure Abbott Laboratories' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Abbott Laboratories is operating at the current time. Most of Abbott Laboratories' value examination focuses on studying past and present price action to predict the probability of Abbott Laboratories' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Abbott Laboratories' price. Additionally, you may evaluate how the addition of Abbott Laboratories to your portfolios can decrease your overall portfolio volatility.
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Global Correlations
Find global opportunities by holding instruments from different markets
Is Abbott Laboratories' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Abbott Laboratories. If investors know Abbott will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Abbott Laboratories listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.07)
Dividend Share
2.12
Earnings Share
3.21
Revenue Per Share
23.183
Quarterly Revenue Growth
0.022
The market value of Abbott Laboratories is measured differently than its book value, which is the value of Abbott that is recorded on the company's balance sheet. Investors also form their own opinion of Abbott Laboratories' value that differs from its market value or its book value, called intrinsic value, which is Abbott Laboratories' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Abbott Laboratories' market value can be influenced by many factors that don't directly affect Abbott Laboratories' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Abbott Laboratories' value and its price as these two are different measures arrived at by different means. Investors typically determine if Abbott Laboratories is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Abbott Laboratories' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.